IP Verse

Pharmaceutical Compositions Comprising Anagrelide - EP2915526

The patent EP2915526 was granted to Galenicum Health SL on Jun 2, 2021. The application was originally filed on Mar 9, 2015 under application number EP15158157A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2915526

GALENICUM HEALTH SL
Application Number
EP15158157A
Filing Date
Mar 9, 2015
Status
Granted And Under Opposition
Apr 30, 2021
Grant Date
Jun 2, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HAMM & WITTKOPPMar 1, 2022HAMM & WITTKOPPWITHDRAWN

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2003158261
DESCRIPTIONUS3932407
DESCRIPTIONWO02058676
DESCRIPTIONWO2010063824
SEARCHEP2367539
SEARCHUS2005008704
SEARCHUS2009324710

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- European Pharmacopoeia-
OTHER- Anonymous, "PUBLIC ASSESSMENT REPORT Decentralised Procedure Anagrelid LERAM 0,5 mg Hartkapseln", Procedure Number: DE/H/5329/001/DC, (20190114), pages 1pp, 1 - 11, XP055799812-
OTHER- Anonymous, "Scientific Discussion", EMEA, (2004), pages 1 - 38-
OTHER- Anonymous, "Shire Pharmaceutical Contracts Ltd.,", Summary of Product Characteristics -Xagrid, (20140718), pages 1 - 24-
OTHER- Anonymous, "Summary of product characteristics - Xagrid", Shire Pharmaceutical Contracts Ltd, (20091116), pages 1 - 24-
OTHER- Anonymous, "Xagrid-Procedural Steps Taken and Scientific Information after the Authorization", EMA/685806/2020, (2020), pages 1 - 27, XP055799784-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents